全文获取类型
收费全文 | 1075367篇 |
免费 | 73340篇 |
国内免费 | 1366篇 |
专业分类
耳鼻咽喉 | 15046篇 |
儿科学 | 34685篇 |
妇产科学 | 28683篇 |
基础医学 | 153629篇 |
口腔科学 | 29816篇 |
临床医学 | 95010篇 |
内科学 | 203973篇 |
皮肤病学 | 24440篇 |
神经病学 | 81522篇 |
特种医学 | 43089篇 |
外国民族医学 | 201篇 |
外科学 | 163524篇 |
综合类 | 21730篇 |
现状与发展 | 1篇 |
一般理论 | 266篇 |
预防医学 | 74622篇 |
眼科学 | 24686篇 |
药学 | 86217篇 |
8篇 | |
中国医学 | 2817篇 |
肿瘤学 | 66108篇 |
出版年
2019年 | 7833篇 |
2018年 | 11388篇 |
2017年 | 8970篇 |
2016年 | 10178篇 |
2015年 | 11357篇 |
2014年 | 15385篇 |
2013年 | 22390篇 |
2012年 | 30775篇 |
2011年 | 32510篇 |
2010年 | 19101篇 |
2009年 | 17906篇 |
2008年 | 30086篇 |
2007年 | 32218篇 |
2006年 | 32841篇 |
2005年 | 31127篇 |
2004年 | 29822篇 |
2003年 | 28623篇 |
2002年 | 27580篇 |
2001年 | 60052篇 |
2000年 | 61511篇 |
1999年 | 50961篇 |
1998年 | 12458篇 |
1997年 | 11017篇 |
1996年 | 11025篇 |
1995年 | 10340篇 |
1994年 | 9345篇 |
1993年 | 8865篇 |
1992年 | 37809篇 |
1991年 | 36286篇 |
1990年 | 35763篇 |
1989年 | 34308篇 |
1988年 | 30887篇 |
1987年 | 30008篇 |
1986年 | 28234篇 |
1985年 | 26469篇 |
1984年 | 19197篇 |
1983年 | 16118篇 |
1982年 | 8826篇 |
1979年 | 17038篇 |
1978年 | 11409篇 |
1977年 | 10232篇 |
1976年 | 8842篇 |
1975年 | 10074篇 |
1974年 | 11656篇 |
1973年 | 11275篇 |
1972年 | 10757篇 |
1971年 | 10096篇 |
1970年 | 9254篇 |
1969年 | 8940篇 |
1968年 | 7917篇 |
排序方式: 共有10000条查询结果,搜索用时 265 毫秒
71.
72.
Characteristics of hyperparathyroid states in the Canadian multicentre osteoporosis study (CaMos) and relationship to skeletal markers
下载免费PDF全文
![点击此处可从《Clinical endocrinology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
73.
74.
75.
76.
77.
Vinke Jeroen Kaper Hans J. Vissink Arjan Sharma Prashant K. 《Clinical oral investigations》2020,24(11):4019-4030
Clinical Oral Investigations - The aims of this study are to assess different saliva substitutes for their efficacy to lubricate the oral cavity, and to relate this oral lubrication to the ability... 相似文献
78.
79.
Aditya Kelkar Caroll Webers Rohit Shetty Jai Kelkar Nikhil Labhsetwar Abhishek Pandit Madhulika Malode Sayali Tidke 《Indian journal of ophthalmology》2020,68(10):2143
Purpose:To evaluate the rate of compliance and the reasons for loss to follow-up in Indian patients with diabetic macular edema (DME), age-related macular degeneration (AMD), and retinal vein occlusion (RVO) being treated with anti-vascular endothelial growth factor (VEGF) therapy.Methods:This was a retrospective single-center study. Patients with DME, AMD, or RVO were eligible if they initiated anti-VEGF therapy between January 2013 and December 2017. Patients'' data were obtained from hospital electronic records, including the number of injections received, visits, details of follow-up, missed appointments, and reasons for loss to follow-up (>365 days).Results:A total of 648 patients were eligible for the study, of which 334 (51.54%) patients were lost to follow-up. Overall, 343 (64.96%) were males and the overall mean (SD) age was 66.40 (7.44) years. A total of 376 (58.0%) patients had a history of diabetes and 364 (56.2%) patients had a history of hypertension. Further, 127 (38.0), 112 (33.5), and 95 (28.4) had DME, AMD, and RVO, respectively and were lost to follow-up. The most commonly reported reason for loss to follow-up was “non-affordability” (n = 120; 41.1%) followed by “no improvement in vision” (n = 83; 28.4%). “No improvement in vision” (42.2%) and “non-affordability” (37.5%) were higher among patients with DME. No association was found in gender- and treatment-wise distribution of reasons for loss to follow-up.Conclusion:The results showed that around half of the patients with DME, AMD, and RVO were lost to follow-up to intravitreal anti-VEGF therapy, and the most common factors were “non-affordability” and “no improvement in vision.” 相似文献